© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Leap Therapeutics, Inc. (LPTX) shows an Average True Range (ATR) of 0.21 and an Enterprise Value of 13.85M. Its average trading volume over the past 3 months is 19.57M, indicating liquidity. These fundamental metrics provide insight into LPTX's underlying financial health and market activity.
Leap Therapeutics, Inc. (LPTX) technical indicators as of January 1, 2026: the SMA 20 is 272.52%, SMA 50 at 325.67%, and SMA 200 at 409.57%. The RSI 14 value is 89.47, suggesting its current momentum. These technical analysis signals help assess LPTX's price trends and potential future movements.
Leap Therapeutics, Inc. (LPTX) stock performance overview as of January 1, 2026: The 52-week high is $3.58 (currently -43.21% below), and the 52-week low is $0.222 (currently 822.18% above). Over the past year, LPTX's performance is -87.51%, compared to the S&P 500's 12.29% change.
According to market data, Leap Therapeutics, Inc. (LPTX) stock's recent performance metrics show that over the last month, LPTX is -33.19%, with a Year-to-Date (YTD) performance of -84.09%. Over the past year, the stock has seen a -87.51% change. These figures summarize LPTX's price movements across various periods, reflecting its historical returns.
According to current financial data, LPTX stock's P/E (TTM) ratio is -0.48, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for LPTX, including P/S (106.52), P/B (0.20), and P/FCF (-0.75), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.